DIOD PAO

DIOD PAO CapEx/D&A

The CapEx to Depreciation Ratio of DIOD PAO (DIOD.ME) as of Nov 2, 2026 is 3.35. In the previous year, CapEx to Depreciation Ratio was 0.53 — a change of 531.04% (higher).

CapEx/D&A

3.35

YoY

531.04%

Last updated:

CapEx to Depreciation Ratio of DIOD PAO is 2023 3.35 . CapEx to Depreciation Ratio of DIOD PAO was 2022 0.53 . It decreases by 531.04% higher compared to the previous year.

The DIOD PAO CapEx/D&A history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/D&A
Date
CapEx/D&A
Jan 1, 2016
0.38 RUB
Jan 1, 2017
3.36 RUB
Jan 1, 2018
1.01 RUB
Jan 1, 2019
0.38 RUB
Jan 1, 2020
0.10 RUB
Jan 1, 2021
1.76 RUB
Jan 1, 2022
0.53 RUB
Jan 1, 2023
3.35 RUB
The DIOD PAO CapEx/D&A history
YEARCapEx/D&AYoY
3.35+531.04%
0.53-69.89%
1.76+1,676.01%
0.10-73.68%
0.38-62.68%
1.01-69.93%
3.36+776.58%
0.38+320.45%
0.09+250.82%
0.03—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DIOD PAO Stock analysis

What does DIOD PAO do? DIOD PAO generates revenue through the manufacturing and sale of pharmaceuticals, dietary supplements, medical cosmetic products, and medical equipment. Its product portfolio includes iodine, selenium, and calcium-based vitamins, as well as silver water purifiers and light therapy apparatus. The company serves healthcare providers, consumers, and medical centers like Mir ekologii, which it owns, through its subsidiaries and affiliated companies. Revenue streams are derived from direct sales of these products and services to end-users and healthcare institutions. The company's main focus is on eco-friendly and natural-based products, targeting consumers seeking health and wellness solutions. Its subsidiaries and affiliated companies facilitate distribution across various segments, including pharmaceuticals, dietary supplements, and medical equipment. The firm's medical center Mir ekologii complements its product offerings by providing healthcare services that align with its natural health focus. DIOD PAO's revenue model relies on the production and sale of its branded products, such as iodine, selenium, and calcium-based vitamins, which are sold through its subsidiaries. The medical equipment segment, including silver water purifiers and light therapy apparatus, contributes to its revenue through direct consumer and institutional sales. The ownership of Mir ekologii allows the company to integrate healthcare services with its product portfolio, enhancing customer retention and cross-selling opportunities. DIOD PAO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DIOD PAO stock

CapEx to Depreciation Ratio of DIOD PAO is 3.35 in 2023.

CapEx to Depreciation Ratio of DIOD PAO changed from 0.53 to 3.35, representing a 531.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio DIOD PAO since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's DIOD PAO with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — DIOD PAO

All Key Metrics — DIOD PAO